Preclinical in vivo CRO for advanced models of pathologies and imaging
Imavita is a preclinical CRO specializing in in vivo models that approximate or replicate human pathologies. Our models enable precise evaluations of drug efficacy, safety, and pharmacokinetics. Utilizing both healthy and pathological models in rodents and non-rodents, we provide customized solutions to study therapeutic mechanisms, validate drug targets, and optimize dosing strategies. Imavita integrates advanced imaging technologies with its in vivo expertise to support drug development pipelines.
Imavita is a preclinical CRO specializing in in vivo models that approximate or replicate human pathologies. Our models enable precise evaluations of drug efficacy, safety, and pharmacokinetics. Utilizing both healthy and pathological models in rodents and non-rodents, we provide customized solutions to study therapeutic mechanisms, validate drug targets, and optimize dosing strategies. Imavita integrates advanced imaging technologies with its in vivo expertise to support drug development pipelines.
With our specific and complete expertise and technologies, as a preclinical CRO we offer you a panel of studies for drug evaluation.
- Efficacy : Assess the therapeutic potential of new compounds.
- Pharmacokinetics (PK) : Analyze absorption, distribution, metabolism, and elimination.
- Drugs tolerance / Safety : Identify potential adverse effects to optimize dosing strategies (non GLP).
Our preclinical in vivo CRO services use a variety of laboratories species.
- Precise analysis of imaging biomarkers from ex vivo models using advanced techniques.
- As a CRO specializing in preclinical models and imaging, Imavita integrates cutting-edge techniques into in vivo studies to deliver advanced non-invasive insights: Live animal behaviour video recording.
- Fluorescence Reflectance and Imaging (FRI), Fluorescence Tomography (FMT) and Bioluminescence: Dynamic monitoring of disease progression.
- Ultrasonography ((low frequency) and Optical Coherence Tomography (OCT): High-resolution analysis of structural and functional changes.
- PET/CT, and MRI (7T, in partnership): Track real-time drug biodistribution and therapeutic effects.
Custom-designed models adapted to your therapeutic goals.
Long experience expertise in replicating complex human disease mechanisms.
Reduced animal usage through longitudinal studies and non-invasive imaging.
Quantitative image analysis for reliable and reproducible results.
What is a preclinical in vivo CRO?
A preclinical in vivo CRO specializes in providing animal models and in vivo studies to support drug discovery and development. It offers services such as efficacy studies, pharmacokinetics (PK), and toxicology evaluations under physiological conditions.
How to integrate imaging into in vivo studies?
Imavita uses advanced imaging techniques like PET/CT, bioluminescence, and fluorescence to provide real-time, non-invasive insights into drug behaviour and disease progression.
